Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 115.80
+1.20 (1.05%)
At close: Jan 30, 2026
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.85 billion as of January 30, 2026. Its market cap has increased by 82.01% in one year.
Market Cap
1.85B
Enterprise Value
1.74B
Revenue
170.24M
Ranking
n/a
PE Ratio
33.80
Stock Price
115.80
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 1.85B, an increase of 847.00%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 1.83B | 8.94% |
| Dec 30, 2025 | 1.68B | 64.05% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 288.96B |
| Novartis AG | 219.13B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 34.26B |
| Medacta Group | 3.39B |
| Tecan Group AG | 1.75B |
| SKAN Group AG | 1.34B |
| Medartis Holding AG | 1.17B |